Noua Zeelandă aprobă utilizarea MDMA pentru tratarea pacienților cu stres post-traumatic

New Zealand has approved the use of pharmaceutical-grade MDMA for treating severe post-traumatic stress disorder (PTSD), becoming the second country to do so after Australia. The treatment will be administered in a controlled clinical setting alongside psychotherapy, with patients required to be at least 18 years old. Vice Prime Minister David Seymour emphasized the need for innovative treatments for PTSD, which significantly impacts lives. While studies in other countries have shown potential benefits of MDMA, the FDA in the United States has not yet approved its medical use, citing insufficient evidence of safety and efficacy.